Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Use the average price of 2015 (~$2.50) and the average price of 2019 (~$0.30). The loss is still similar.

Pre-COVID IPiX largely failed as a company. No phase 3 advancement, no lucrative partnerships, shareholder decimation, etc.

That is why we get absolutely no credit even though we may be a few months out from a new SoC for COVID.

Just crossing fingers and hoping Leo's hail Mary is caught by someone.

GO IPIX!